|
ARGAPH11B
|
Only present in human genome |
Segmental duplication of ARGAPH11A; novel carboxy-terminal amino acid sequence due to a novel splice donor site |
Mitochondrion |
Increased BP proliferation, subsequent higher neuron numbers, induction of cortical expansion and folding, improved memory flexibility |
Increase in mitochondrial Ca2+ concentration leading to enhanced glutaminolysis |
|
CROCCP2
|
Paralogous loci present in the Catarrhini group; Expression during corticogenesis is proposed to be unique to humans |
Partial segmental duplication of the ancestral gene CROCC |
Cytoplasm (with perinuclear localization, presumably at the Golgi apparatus) |
Increased AP and BP proliferation, subsequent increase in neuron numbers |
Inhibition of IFT20 resulting into decreased ciliogenesis and activation of mTOR pathway (for BPs) |
| hTKTL1
|
Present in mammals; modern human-specific version |
Modern-human specific substitution of lysine with arginine due to a single nucleotide mutation |
Cytoplasm |
Increased bRG abundance, subsequent higher neuron numbers |
Upregulation of the pentose phosphate pathway and fatty acid synthesis |
|
KIF18A and KNL1
|
Widely conserved genes; modern human-specific versions |
One and two modern human-specific amino acid substitutions respectively |
Kinetochore |
Metaphase prolongation and improved chromosome segregation fidelity in APs |
Regulation of chromosome positioning and kinetochore microtubule attachment during mitosis |
|
NOTCH2NLA-C
|
Only present in human genome |
Multiple segmental duplication rounds of the ancestral NOTCH2NLR; Three human-specific paralogous (NOTCH2NLA, -B, -C) |
Cytoplasm (suggested to be secreted) |
Increased AP proliferation, delayed neuronal differentiation (for NOTCH2NLB), increased bIP proliferation (for NOTCH2NLA) |
Activation of Notch signaling |
|
SP0535
|
Only present in human genome |
De novo origin; single-base mutation and stop codon escape due to a two-base deletion in the human ENST00000370535 locus |
Cytoplasm |
Increased proliferation of APs, elevated number of bIPs, subsequently higher number of neurons, induction of cortical expansion and folding |
Increase of Src phosphorylation (associated with cell proliferation) via releasing it from ATP1A1-Src complex |
|
SRGAP2C
|
Only present in human genome |
Incomplete segmental duplication of SRGAP2A (its “grandmother”), subsequent duplication of SRGAP2B (its “mother”); loss of SH3 and Rho-GAP domains |
Cytoplasm (dendrites of cortical neurons) |
Increased progenitor proliferation; induction of “human-like” developmental features as sustained radial migration, neoteny of spine and synapse development, delayed myelination, increased spine size and density, increased synaptic density, prolongation of brain development; cognitive improvements |
Functional inhibition of the ancestral SRGAP2A via physical heterodimerization |
|
TBC1D3
|
Present in Simian genomes but copy number and organization vary; human-specific carboxy-terminal amino acid sequence |
Large-scale chromosomal rearrangements and duplication events suggestive of independent expansion in each lineage |
Nucleus in oSVZ cells, cytoplasm/membrane in VZ/iSVZ and CP cells |
aRG delamination and bRG proliferation, induction of cortical folding |
Proposed theories include: (i) Activation of IGF and EGF pathways; (ii) inhibition of G9a-facilitated H3K9me2 |